Cart
sales@molnova.com
ZM 306416
CAS No. 690206-97-4
ZM 306416( CB-676475 )
Catalog No. M15640 CAS No. 690206-97-4
ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 90 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 354 | In Stock |
|
| 100MG | 527 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZM 306416
-
NoteResearch use only, not for human use.
-
Brief DescriptionZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
-
DescriptionZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
-
In VitroZM-306416 selective anti-proliferative effect toward the EGFR addicted NSCLC cell lines H3255 and HCC4011 (IC50=0.09±0.007 μM and 0.072±0.001 μM respectively), while sparing the wild type EGFR cell lines A549 and H2030 (IC50>10 μM). ZM-306416 is also found to inhibit the ABL in vitro kinase activity with a less potent IC50 value of 1.3±0.2 μM toward the ABL kinase.
-
In Vivo——
-
SynonymsCB-676475
-
PathwayTyrosine Kinase
-
TargetBcr-Abl
-
RecptorAbl| Src| VEGFR1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number690206-97-4
-
Formula Weight333.74
-
Molecular FormulaC16H13ClFN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 67 mg/mL (200.75 mM)
-
SMILESCOC1=CC2=NC=NC(NC3=CC=C(Cl)C=C3F)=C2C=C1OC
-
Chemical Name4-[(4'-Chloro-2'-fluoro)phenylamino]-6,7-dimethoxyquinazoline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antczak C, et al. J Biomol Screen, 2012, 17(7), 885-899.
molnova catalog
related products
-
Solanesol
Phytochemical present in tobacco leaf. Starting material for synthesis of co-enzyme Q10. Exhibits antiulcer activity.
-
GNF-5
GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, is a selective non-ATP competitive inhibitor of Bcr-Abl with an IC50 value of 0.22±0.1 uM (Wild type Abl).
-
TIC10 isomer
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
